Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis-Reference-Cited by-同舟云学术

Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis

Published:2023 Issue: Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Wang Hao¹^ORCID,Li Yinuo¹^ORCID,Wang Yanan¹^ORCID,Shang Xiumin²^ORCID,Yan Zhongxin¹^ORCID,Li Shengli³^ORCID,Bao Wei¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

2. Department of Obstetrics and Gynecology, Changning Maternity and Infant Health Hospital, Shanghai, China.

3. Department of Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funder

National Natural Science Foundation of China

National Natural Science Foundation of Shanghai

Clinical Project of Shanghai Municipal Health Commission

Foundation of Shanghai Sailing Program

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e13

Reference39 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

3. The rediscovery of platinum-based cancer therapy

4. Impact of Chemotherapy on Extracellular Vesicles: Understanding the Chemo-EVs

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance;Biomolecules;2024-09-02

2. SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis;Experimental and Therapeutic Medicine;2024-07-26

3. Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers;Frontiers in Oncology;2024-04-26